Skip to main content

Table 4 Neonatal outcomes in live birth cycles stratified by the ovarian stimulation method

From: Letrozole-induced endometrial preparation improved the pregnancy outcomes after frozen blastocyst transfer compared to the natural cycle: a retrospective cohort study

 

Natural

Letrozole

P-value

Live birth, n

746

808

 

Female age

35.5 ± 0.1

35.6 ± 0.1

0.6882

Male age

37.8 ± 0.2

37.5 ± 0.2

0.2048

Body mass index

20.6 ± 0.1

20.8 ± 0.1

0.1734

Pregnancy complications, n (%)

37 (5.0)

52 (6.4)

0.2110

Hypertensive disorders of pregnancy, n (%)

8 (1.1)

3 (0.4)

0.0996

Gestational diabetes mellitus, n (%)

4 (0.5)

7 (0.9)

0.4380

HELLP syndrome, n (%)

0 (0)

1 (0.1)

0.3365

Preterm premature rupture of membrane, n (%)

1 (0.1)

4 (0.5)

0.2093

Low-lying placenta, n (%)

4 (0.5)

4 (0.5)

0.9099

Placenta previa, n (%)

9 (1.2)

10 (1.2)

0.9554

Placental abruption, n (%)

1 (0.1)

2 (0.3)

0.6107

Others, n (%)

1 (0.1)

2 (0.3)

0.6107

Caesarean section rate, n (%)

220 (29.5)

216 (26.7)

0.2267

Gestational age, weeks

39.0 ± 0.1

39.0 ± 0.1

0.6539

Preterm delivery (< 37 weeks), n (%)

40 (5.4)

45 (5.6)

0.8575

Birth length (cm)

49.1 ± 0.1

49.0 ± 0.1

0.7309

Birth weight (g)

3,031 ± 16

3,017 ± 15

0.5208

Low birth weight (< 2,500 g), n (%)

66 (8.9)

72 (8.9)

0.9648

Small for gestational age

31 (4.2)

34 (4.2)

0.9589

Large for gestational age

126 (16.9)

116 (14.4)

0.1688

Infant sex

  

0.9515

Male, n (%)

388 (52.0)

419 (51.9)

 

Female, n (%)

358 (48.0)

389 (48.1)

 

Birth defect, n (%)

31 (4.2)

36 (4.5)

0.7755

  1. The data are shown as means and standard errors of the mean, unless otherwise indicated